Niniejsza strona internetowa należy do spółki Medical Continence Centers S.A. z siedzibą w , która prowadzi przy jej wykorzystaniu ofertę publiczną oraz akcję promocyjną oferty publicznej w rozumieniu przepisów ustawy z dnia 29 lipca 2005 r. o ofercie publicznej i warunkach wprowadzania instrumentów finansowych do zorganizowanego systemu obrotu oraz o spółkach publicznych.
This material is for promotional purposes only. This public offering does not require prospectus.
  • 240,700 PLN raised capital
  • Project
    finished
  • 297 investors
  • 999,750 PLN share issue objective
  • 9.09 % equity on offer
  • 50 PLN stock price
  • 19,995 no. of stocks
  • 05.06.2019 end date
  • 150,000 PLN minimum threshold

WE BRING PROFESSIONALS TOGETHER

Medical Continence Centers S.A. (www.medicalcontinencecenters.eu) was created by people with a passion for developing cooperation in interdisciplinary medicine. In Poland, just as in most countries around the world, not many urologists and gynaecologists specialize in treating incontinence, and their cooperation usually ends in making declarations.

WE SET STANDARDS

Medical Continence Centers S.A. is the first project in Poland which established an infrastructural framework for ongoing, partner cooperation of the three medical professions which are of key importance for successful therapy: urologists, gynaecologists and physiotherapists.

WE INTRODUCE A NEW QUALITY

By combining business and medical competencies with international experience acquired over many years, we create a new quality in looking after the difficult patient who will never be a priority for public healthcare.

BONUSES FOR MCC INVESTORS

From 50 PLN (1 share)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • a 50% one-time personal discount on a specialist visit to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist including an ultrasound)

The discount entitles to medical consultations with: MD or MD/PhD.
Valid for two years.

From 250 PLN (5 shares)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • an MCC Standard card - a 50% discount on three specialist visits to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist, including an ultrasound)

A bearer card.
The discount entitles to medical consultations with: MD or MD/PhD.
Valid for two years.

From 500 PLN (10 shares)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • an MCC Standard Plus card - a 50% discount on three specialist visits to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist, including an ultrasound) and a 50% discount on a package of five sessions with a urological or urogynaecological physiotherapist.

A bearer card.
The discount entitles to medical consultations with: MD or MD/PhD.
Valid for two years.

From 2 500 PLN (50 shares)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • a MCC Silver card - a 50% discount on three specialist visits to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist, including an ultrasound) and a 50% discount on a package of 20 sessions with a urological or urogynaecological physiotherapist.

A bearer card.
Applicable to the first 100 registrations.
The discount entitles to medical consultations with: MD or MD/PhD or Ass. Prof.
Valid for three years.

From 5 000 PLN (100 shares)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • a MCC Gold card - a 75% discount on five specialist visits to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist, including an ultrasound) and a 75% discount on a package of 40 sessions with a urological or urogynaecological physiotherapist (a maximum of 40 sessions).

A bearer card.
Applicable to the first 50 registrations.
The discount entitles to medical consultations with: MD or MD/PhD or Ass. Prof. or Prof.
Valid for three years.

From 50 000 PLN (1000 shares)

  • stock certificate
  • invitation to the Annual General Meeting
  • right to the dividend
  • a MCC Platinium card - a 90% discount on five specialist visits to a doctor at the MCC (a urologist or gynaecologist or pediatric urologist, including an ultrasound) and a 90% discount on a package of 100 sessions with a urological or urogynaecological physiotherapist.

A bearer card.
Applicable to the first 10 registrations.
The discount entitles to medical consultations with: MD or MD/PhD or Ass. Prof. or Prof.
Valid for three years.

COMPETITION FOR SHAREHOLDERS

A competition will be organized among all the MCC Shareholders, in which they will choose the location of the second Continence Center.
One shareholder has one vote.
The location will be selected from among 8 proposed by the MCC Board.

INCONTINENCE, I.E. UI

Urinary incontinence (UI) does not kill, but it effectively ruins people’s lives. It is a chronic and embarrassing ailment.

WHO DOES UI AFFECT?

MEN 3-11%

  • after prostate surgery
  • after chemo- or/and after radiotherapy
  • with erectile dysfunction and reduced libido
  • aged 70+

WOMEN 30-60%

  • after pregnancy
  • after menopause
  • after gynecological procedures
  • after chemo- or/and after radiotherapy
  • aged 65+

CHILDREN

  • with night soaking

UI - DIFFICULT QUESTIONS

  • Who treats UI and where?
  • What kind of UI do I have?
  • Why can’t doctors help me?
  • Can anyone help me?
  • Do I have to undergo surgery?
  • What does the healthcare system actually offer me?

TODAY
NO COMPREHENSIVENESS OR COMPLEMENTARITY

TOMMORROW
ONE PLACE = COMPREHENSIVE CARE

WHAT IS MEDICAL CONTINENCE CENTERS?

A project which brings together the best specialists on UI treatment who, based on international standards, will ensure that the patient:

  • is properly diagnosed
  • goes through successive stages of therapy
  • makes use of unique and innovative methods reducing the risk of side effects to a minimum
  • will receive modern support for further “navigation” of the system irrespective of the final outcome of the therapy

CONTINENCE CENTER

  • comprehensive care
  • complementarity with hospitals
  • ongoing communication
  • personalized therapy methods with the use of innovative equipment

MEDICAL NICHE WITH GOOD PROSPECTS

The progressive ageing in Europe’s population, civilization changes and growing social awareness require not only increasing the specialist offer but also expanding and improving the quality of services.
This creates an excellent opportunity for investors.

Launching a new generation of interdisciplinary medical centers requires cooperation which goes beyond exact medicine. Thanks to the knowledge and qualifications of its team and experience in creating interdisciplinary medical cooperation acquired over the years, MCC has every reason to become the leader in looking after people with lower urinary tract symptoms (LUTS).

What makes MCC stand out, in particular, among many other private medical centers in the Polish market is a strategy for raising capital for development, through which we educate, engage and, therefore, constantly expand the community - our ambassadors.

MODEL CONTINENCE CENTER

Our primary objective is to launch the first, model medical center, based on collaboration among well-qualified urologists, gynaecologists and physiotherapists. Launching the first, model center in Warsaw will enable us to implement and modify the proposed solutions in practice. Our relations and experience of more than 10 years in building up a community of patients with incontinence in Poland and worldwide are the key to success. Based on our knowledge and experience we have worked out an effective business model.

CHALLENGES WE HAVE ALREADY FACED:

STAFF

system of work, remuneration, training and motivation

OPTIMAL OPERATIONS OF A CENTER

identification and elimination of “bottlenecks”

TECHNOLOGICAL SUPPORT

identification of suppliers of specialist equipment

COMPETITIVE PRICES

designing an attractive pricing strategy

EFFECTIVE BUSINESS MODEL

low capital intensity, quick return on investment

CORPORATE SOCIAL RESPONSIBILITY

building up a dedicated community

MODEL CENTER IN WARSAW
AND
MORE CENTERS IN OTHER CITIES

Launching the first, model center in the heart of Warsaw is the commencement of the pursuit of the development strategy of Medical Continence Centers S.A.

In total, we plan to open 10 MCC centers over the first five years.

WORLD - POLAND - MASOVIA REGION

The UI problem is growing in step with ageing societies. An additional factor, apart from demographic changes, is civilization changes. People living in the wealthiest countries are paying more and more attention to the quality of life and not just its length. As a result of the increasing cult of eternal youth, attractive appearance and fitness, including sexual fitness, incontinence has become one of the key health challenges for the generations to come.

World

Source: Global Forum on Incontinence 2018, Rome, Ian Milsom, How big is the problem? Incontinence in numbers.

Anyone can develop UI, however, it is women who suffer from it more frequently. It is estimated that urinary incontinence affects women even three times more often than men.

This difference decreases with age.

Poland

7-YEAR REGISTERED INCIDENCE

UI patients registered for the first time, as new cases of the ilness, with the public healthcare system in the years 2009-2016, who did not die by 31/12/2016

In total: 403,7 thousand people in Poland

On average: 10,2 thousand people a year (Masovian Voivodeship)

Source: Map of health needs prepared by the Analyses and Strategy Department of the Ministry of Health in 2018 based on data from the NFZ (National Health Fund) and the GUS (Central Statistical Office) for 2016. Data in thousands of people.

MASOVIA

UI INCIDENCE BY AGE (MASOVIAN VOIVODESHIP)

Urinary incontinence affects people of all ages, however, most patients are elderly people (mainly women after menopause).

This relationship, in combination with the progressive ageing in Polish society, creates a favourable market situation for Medical Continence Centers. According to experts, this trend will continue for the next 30-40 years, offering space for growth for incontinence treatment clinics.

Source: Map of health needs prepared by the Analyses and Strategy Department of the Ministry of Health in 2018 based on data from the NFZ (National Health Fund) and the GUS (Central Statistical Office) for 2016.

INCIDENCE BY GENDER

INCIDENCE BY PLACE OF RESIDENCE

Source: Map of health needs prepared by the Analyses and Strategy Department of the Ministry of Health in 2018 based on data from the NFZ (National Health Fund) and the GUS (Central Statistical Office) for 2016.

UI - FORECAST

The very first incontinence treatment center managed by Medical Continence Centers will be established in the Masovian Voivodeship. According to the forecasts for the years 20202029, it is in Masovia that the said problem will affect the most new people. The research conducted for the “averaged-out” demographic variant shows that in that one voivodeship alone over eight thousand new people will be joining the group of those suffering from urinary incontinence each year.

Source: Map of health needs prepared by the Analyses and Strategy Department of the Ministry of Health in 2018 based on data from the NFZ (National Health Fund) and the GUS (Central Statistical Office) for 2016.
Source: A report by the GUS (Central Statistical Office) “Healthcare in households in 2016”

HEALTHCARE MARKET IN POLAND

As society grows richer, more and more attention is paid not only to living healthily but also in comfort and fitness.

The center run by Medical Continence Centers S.A. will form part of the trend of the growing popularity of private healthcare centers - today, nearly 40% of all procedures are performed by private centers.

WHY MCC?

MCC is not in competition with hospitals. On the contrary, it is the missing element of comprehensive care, which Polish patients deserve. Our model assumes providing constant care which consists of preparing the Patient both before a necessary visit to a hospital (e.g. delivery, surgical procedure) and special, urological care after they return home.

The Continence Center’s business model is not to be confined exclusively to well-off people, whose numbers have been growing in Poland for many years. On the contrary, while maintaining top quality, we trigger mechanisms combining social involvement with increased access to the services we offer.

COMPETITIVE EDGE HERE AND NOW

  • unique knowledge backed by many years of experience
  • comprehensiveness in one place
  • interdisciplinary and complementary approach
  • vision of national and international development
  • readiness for long-term cooperation with a difficult patient
  • coordination of care
  • niche topic - global problem

COMPETITION - MASOVIAN VOIVODESHIP

In the Masovian Voivodeship, there are 63 service providers operating in the UI therapy area, including 18 responsible for 80% of hospitalizations of people with UI.

Source: Map of health needs prepared by the Analyses and Strategy Department of the Ministry of Health in 2018 based on data from the NFZ (National Health Fund) and the GUS (Central Statistical Office) for 2016.

WE KNOW WHO IS LOOKING FOR HELP AND WE KNOW HOW TO HELP THEM

WHAT ARE WE RAISING FUNDS FOR?

Designing and decorationg model center (20%)
Specialist equipment (20%)
Web platform and mobile app (8%)
Expanding and training a medical team (30%)
Marketing and sales activities (22%)

DESIGNING AND DECORATING A MODEL CENTER IN WARSAW
200 000 PLN

Functionality and aesthetic qualities are the two basic criteria which will guide us in preparing for the opening of a model Continence Center in Warsaw. The solutions which we will work out will be used to launch more centers in Poland.

SPECIALIST EQUIPMENT
200 000 PLN

MCC designs its own specialist equipment which is used for urogynaecological physiotherapy and urinary rehabilitation. We entrust its manufacture with a Polish producer of international renown (USA, Germany, Australia). It will be complemented by well-tried diagnostic equipment.

WEB PLATFORM ALONG WITH A MOBILE APPLICATION
80 000 PLN

One of the assets of MCC’s offer is knowledge of the system which functions in Poland. Through a modern application we will be able to help each UI patient to “navigate” the said system.

EXPANDING AND TRAINING A MEDICAL TEAM
300 000 PLN

Medicine is one of the most innovative areas. That is why medical staff need to update their knowledge constantly by participating in academic events and workshops. From the outset, MCC’s business model has assumed the provision of systematic organizational and financial support offered to our employees to allow them to improve their skills on a regular basis both at national and international level.

MARKETING AND SALES ACTIVITIES
220 000 PLN

The key criterion of success for the MCC project is to achieve a center occupancy rate of 90% by the end of the first year from its launch. Incontinence, as an embarrassing ailment, requires undertaking suitable educational and marketing activities so as to ensure that every UI patient knows where to seek help first.

ABOUT US

The Medical Continence Centers S.A. team is a group of motivated people who share a common vision, led by a management board with considerable business and industry-specific experience.

TOMASZ MICHAŁEK

Chief Executive Officer (CEO)

Co-founder of the MCC

  • manager with 20 years’ experience (Warsaw Voice S.A., WV Marketing Sp. z o.o., OCI Sp. z o.o., Fishermen Sp. z o.o.)
  • publisher and editor in chief of NTM Quarterly - published since 2002
  • member of the Executive Council of the World Federation of Incontinence Patients since 2006
  • in the years 2008-2016, a member of the Continence Promotion Committee of the International Continence Society
  • plenipotentiary of the Management Board for international cooperation of "UroConti" Association
  • organizer of multidisciplinary medical congresses (Woman and Man, Pharmacy 21, Healthy Ageing)
  • consultant for medical and pharmaceutical industries and scientific associations

ANDRZEJ PRZYBYŁA, MD/PhD

Chief Medical Officer (CMO)

Co-founder of the MCC

  • urologist and andrologist with many years’ experience
  • specialist in the treatment of UI, sexual disorders, the ageing male
  • pioneer of urological rehabilitation in Poland
  • co-originator of urological rehabilitation standards in Germany
  • in the years 2012-2014, chief urologist at Deutsche Rentenversicherung (the equivalent of the National Social Insurance Institution)
  • certified member of Deutsche Kontinenz Gesellschaft
  • award from the "Gladiator" Association for Men with Prostate Diseases 
  • originator of the Andros Project

SUPERVISORY BOARD

People who support the Company with their knowledge and experience.

PROF. PIOTR BŁĘDOWSKI

Chairman of the Supervisory Board

Professor (PhD) of Economic Sciences. Director of the Institute of Social Economy at the Warsaw School of Economics (SGH). Specialist in social gerontology. In the years 2005-2013, he was Chairman of the Polish Society of Gerontology (PTG) and Deputy Chairman in the years 2014-2017.

BEATA TRESZCZYŃSKA

Member of the Supervisory Board

Managing director of a pharmaceutical company Laboratorios Farmaceuticos ROVI S.A. in Poland. In the years 2003-2011, she was General Director in Poland and CEE of the Healthcare Department of SCA Hygiene Products (the TENA brand - the global leader in absorbent products for people with urinary incontinence). In the years 2011-2016, she managed the operations of Reckitt Benckiser Pharmaceuticals in CEE.

MARIA WIELGOSZ

Member of the Supervisory Board

legal advisor, partner managing the law firm Wielgosz i Wspólnicy. Specialist in medical law, medical errors, protection of personal rights and intellectual property rights as well as damage liability.

TEAM

I.e. well-qualified and positively motivated staff

Karolina Ciepiela

Development Specialist

Anita Poryszewska

Development Specialist

Katarzyna Baj

Administration Specialist

Milena Bękarska

Marketing Specialist

Andrzej Korecki

IT Manager.

Piotr Bobin

Finance and Accounting Manager

INVESTMENT STRATEGIES FOR THE INVESTOR

Sale of shares to another person at any time during the investment and at a freely agreed price

Sale of shares on New Connect (planned entry in three years)

Sale of shares on the Warsaw Stock Exchange (planned entry after five years)

Repurchase of shares by the Company (calls for the repurchase of shares announced by the General Shareholders’ Meeting in accordance with the Articles of Association)

FAQ

Frequently Asked Questions

From the outset we want to carry out the project with a social group of investors, as broad and dedicated as possible. By becoming an MCC shareholder, you may help yourself and your family and friends. This is very important, taking into account the still embarrassing nature of UI as an ailment. We owe a lot of inspiration to the patients’ association UroConti which has been functioning dynamically in Poland for 10 years. There, the UI problem has been talked about openly for years, and sharing experience is invaluable.

The subscribed shares will be allotted within 2 (two) weeks from the last day of the period of subscription for shares. An announcement about the allotment of shares will be made within 1 (one) week from the date of the allotment of shares.

Once the issue has been completed, the Company will file an application with the National Court Register (KRS) to register an increase in the share capital. When the Court has registered the increase, the investors will become shareholders; a share register will be created, and share documents will be issued to the new shareholders.

The valuation of the Company consists of several elements. Medical Continence Centers is managed by experienced professionals who have knowledge which is unique for that market segment. Extensive, international professional experience, combined with an excellent knowledge of the medical staff market in Poland, offers a high probability that the project will be successful.

The market for people seeking help in the Masovian Voivodeship and, more broadly, in Poland has been growing for many years, and this trend will continue. This can be seen clearly in the analyses and forecasts prepared by the Ministry of Health (up until 2031) and a number of other institutions which analyse demographic changes in Poland. Furthermore, for many years we have observed a gradual shift among increasingly wealthy society from public healthcare to the private sector.

The measurement was based on a conservative forecast of cash flows over a period of five years and the valuation of the market in which the Company intends to develop, where the following elements will be important:

  1. Market size, description and development forecast
  2. Competitive edge
  3. Qualifications and experience of the team
  4. Location of the centre

Yes - according to the law, shares may be resold further at your own discretion and based on your own valuation.

Holding shares does not entail any obligations. Once a year you will receive an invitation to the General Shareholders’ Meeting from us.

Yes - so far many companies have carried out this type of action. An important piece of information is that the action is reported to the Polish Financial Supervision Authority.

There are several possibilities:

  • sale of shares with a discount card to another person at any time during the investment and at a freely agreed price
  • sale of shares on New Connect (planned entry in three years)
  • sale of shares on the Warsaw Stock Exchange (planned entry after five years)
  • repurchase of shares by the Company (calls for the repurchase of shares announced by the General Shareholders’ Meeting in accordance with the Articles of Association)
  • repurchase of shares by the Company’s founders

We do not rule out paying a dividend, however, over the first three years we shall encourage shareholders to reinvest most of the profits for the sake of the Company’s further development.

Irrespective of how the missing funds are raised, MCC will continue in operation. However, it will be necessary to fall back on additional, other sources of finance: a private placement, bank loan, leasing the equipment or attracting a strategic investor.

At present, the sources of such financing are not being taken into account, because we assume that we will manage to raise the entire amount by way of a public issue.